SYDNEY, AUSTRALIA: BCAL Diagnostics Limited (ASX:BDX) has announced the appointment of Shane Ryan as the new CEO, effective from April 2, 2024. Ryan, previously the company’s COO, will lead the launch of the innovative breast cancer test, BREASTEST™, and drive the company’s commercialisation efforts. Ryan’s extensive experience in biotechnology product commercialisation, notably his successful launch…
All posts tagged BCAL Diagnostics
BCAL Diagnostics appoints Dr John Hurrell as CEO
SYDNEY, AUSTRALIA: BCAL Diagnostics Limited announced the appointment of experienced life science and healthcare executive Dr John Hurrell as its Chief Executive Officer (CEO). Dr Hurrell has developed and successfully commercialized multiple products and services in life sciences and diagnostics over a career in the industry spanning more than 35 years. He has developed and…
BCAL Diagnostics lists on ASX after raising $10 million in IPO
SYDNEY, AUSTRALIA: BCAL Diagnostics listed on the Australian Securities Exchange (ASX) following an Initial Public Offering (IPO) that raised $10 million from investors. The offer saw the issue of 40 million new shares at 25 cents per share, valuing BCAL at $51.7 million. BCAL is developing a non-invasive laboratory blood test for the detection of…